For drug information, click here.
Helping patients along their journey.
Primary periodic paralysis can be confusing and difficult to diagnose. Patients require a coordinated care team. Prescribers to care and diagnose, payors to provide adequate coverage and pharmaceutical companies to continue researching. As a specialty pharmacy, we’re here to lead and offer patients the support they deserve.
Our primary periodic paralysis program is designed to help the patient achieve the best results. We exclusively dispense KEVEYIS™, the first FDA-approved drug to treat primary periodic paralysis. Together with our 24/7 clinical support and packaging designed to optimize adherence, we treat our patients with care that is truly high-touch.